INHIBITION OF REDD1 EXPRESSION FOR THE REDUCTION OF GLUCOCORTICOID-INDUCED SIDE EFFECTS

by E. S. Lylova, A. V. Savinkova, E. M. Zhidkova, K. I. Kirsanov, M. G. Yakubovskaya, I. V. Budunova, E. A. Lesovaya
Published 2020-12-01

Modern approaches for the screening of epigenetically active xenobiotics

by V. P. Maksimova, P. E. Bugaeva, E. M. Zhidkova, O. G. Usalka, E. A. Lesovaya, G. A. Belitsky, M. G. Yakubovskaya, K. I. Kirsanov
Published 2019-11-01

COMPARATIVE ANALYSIS OF BIOLOGICAL EFFECTS OF SELECTIVE ACTIVATOR OF THE GLUCOCORTICOID RECEPTOR CPDA ON DIFFERENT SUBTYPES OF BREAST CANCER CELL LINES

by E. M. Zhidkova, K. A. Kuzin, L. R. Tilova, A. V. Savinkova, O. I. Borisova, M. D. Lavrova, V. P. Maximova, K. I. Kirsanov, M. G. Yakubovskaya, E. A. Lesovaya
Published 2017-12-01

EPIGENETIC EFFECTS OF ENZASTAURIN – A NEW ASPECT IN THE MECHANISM OF ACTION OF AN ANTICANCER DRUG FROM PROTEIN KINASE INHIBITORS

by V. P. Maksimova, J. V. Makus, O. G. Usalka, E. S. Lylova, P. E. Bugaeva, E. M. Zhidkova, D. A. Fedorov, O. P. Lizogub, E. A. Lesovaya, G. A. Belitsky, M. G. Yakubovskaya, K. I. Kirsanov
Published 2020-09-01

VARIANTS AND PERSPECTIVES OF DRUG REPURPOSING FOR CANCER TREATMENT

by A. V. Savinkova, E. M. Zhidkova, L. R. Tilova, M. D. Lavrova, E. S. Lylova, K. A. Kuzin, A. Yu. Portyannikova, V. P. Maximova, A. V. Kholodova, O. A. Vlasova, T. I. Fetisov, K. I. Kirsanov, G. A. Belitskiy, M. G. Yakubovskaya, E. A. Lesovaya
Published 2018-07-01